You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Novel treatment of posttraumatic stress disorder
SBC: ANAGIN Topic: 101DESCRIPTION provided by applicant The present application andquot Novel Treatment for Posttraumatic Stress Disorderandquot addresses the critical need for efficacious treatments for posttraumatic stress disorder PTSD A key neural signaling cascade activated by a trauma experience is initiated by the excitatory neurotransmitter glutamate Activation of the NMDA receptor a glutamate receptor ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Point-of-care immunoassay for early diagnosis of pertussis
SBC: DXDISCOVERY INC Topic: NIAIDDESCRIPTION provided by applicant Pertussis is a serious and potentially life threatening respiratory disease caused by the bacterium Bordetella pertussis Worldwide million people become ill with pertussis each year and of these patients die Despite high vaccine coverage in the United States there were still over pertussis cases reported in the U S in Rapid diagn ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Identification and Validation of Targets of Phenotypic High Throughput Screening
SBC: Prosolia, Inc. Topic: NIGMSDESCRIPTION: Development of an Intelligent Sample Introduction System for Mass Spectrometry There is a pressing need for new technologies that enable rapid measurements without significant compromise to the analytical data. Herein, we propose to develop arobust mass spectrometry (MS) based surface sampling device that enables direct analysis of a variety of materials including biological tissue a ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
SBIR TOPIC321:CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARDS AND GLY
SBC: OMICRON BIOCHEMICALS, INC. Topic: NCICell-surface oligosaccharides appended to proteins and lipids are key binding epitopes in many critical biological processes, including bacterial infection, cell development and the immune response. Understanding these processes at the molecular level requires access to a wide range of oligosaccharides of known structure to support investigations of enzyme substrate binding and specificity, to ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Novel VLP Adjuvant based on the VesiVax system
SBC: Euclid Diagnostics LLC Topic: NCIDESCRIPTION (provided by applicant): Over one million prostate biopsies are performed in the US each year to diagnose approximately 200,000 cases of prostate cancer. The majority of these biopsies are performed needlessly. The overall objective of this project is to develop a secondary prostate cancer diagnostic test that can be performed on men with elevated PSA in order to identify patients in n ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Portable device for monitoring water balance in elderly
SBC: 3DT HOLDINGS, LLC Topic: NHLBIDESCRIPTION (provided by applicant): Transseptal (TS) access for left heart procedures is an important and rapidly growing space for diagnostics and therapy delivery with an expected total of over 10 million U.S. patients. In the U.S. and/or Europe, TS access procedures are used for atrial fibrillation (AF) ablation, left atrial appendage (LAA) closure, patent foramen ovale (PFO) closure, and trea ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
NIEHS- Device Agnostic Environmental/Agent Data Collection and Integration with
SBC: APEX Therapeuitcs, Inc. Topic: NCIDESCRIPTION (provided by applicant): Our long-term goal is to develop a novel therapeutic strategy for childhood acute lymphoblastic leukemia (ALL), with focus on relapsed T-cell leukemia. We intend to accomplish this by targeting a unique molecular masterregulator using a new generation of compounds. ALL is the most frequent cancer of the childhood. Although significant progress has been achieved ...
SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health -
Mild Hypothermia Catheter for Reperfusion Injury
SBC: 3DT HOLDINGS, LLC Topic: NHLBIABSTRACT ST segment myocardial infarction (STEMI) is a serious acute coronary condition that affects 500,000 Americans each year and results in significant U.S. healthcare costs ( 31B/year for acute MI treatment). STEMI mortality directly relates to the extent of the total myocardial injury and even with the gold standard of reperfusion, up to 50% of the total myocardial injury can be related to ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Cost-Effective OCT Detection of Vision-Threatening Macular Edema
SBC: AEON IMAGING LLC Topic: NEIDESCRIPTION (provided by applicant): I The overall goal of the proposed SBIR program is to implement and evaluate a low cost, portable retinal camera, the Digital Light Ophthalmoscope (DLO), with retinal thickness measurement functionality provided by optical coherence tomography (OCT). The combined DLO-OCT system will cost-effectively identify patients with vision-threatening macular edema for r ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A NOVEL TARGETED DELIVERY SYSTEM FOR CANCER TREATMENT AND DIAGNOSIS
SBC: ENDURX PHARMACEUTICALS INC Topic: NCIDESCRIPTION (provided by applicant): Glioblastoma multiforme (GBM) or glioblastoma, is the most common and aggressive malignant primary brain tumor in humans. An effective treatment that increases patient survival would represent a significant advance inthe field, and provide a desperately needed new therapy for this deadly disease. EnduRx is focused on the development of new, targeted systems f ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health